Better Dividend Stock: Johnson & Johnson or Pfizer?
Investors might think of several attributes when Johnson & Johnson (NYSE: JNJ) and Pfizer (NYSE: PFE) are mentioned. The longevity and stability of the two companies could come to mind. So could dividends. Both J&J and Pfizer have been longtime favorites for income-seeking investors.
But which of these two healthcare giants is the better dividend stock? Here's how Johnson & Johnson and Pfizer stack up against each other.
Image source: Getty Images.
Source Fool.com
